Publications by authors named "Gandhi Damaj"

100Publications

Autoimmune haemolytic anaemia associated with COVID-19 infection.

Br J Haematol 2020 Jul 27;190(1):29-31. Epub 2020 May 27.

Hôpital Avicenne, Assistance Publique - Hôpitaux de Paris, Université Paris 13, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16794DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267601PMC
July 2020

Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.

Neurology 2020 03 6;94(10):e1027-e1039. Epub 2020 Jan 6.

From Service de Neurologie 2-Mazarin, Sorbonne Université, IHU, ICM (C. Houillier, A.A., D.D., H.D., D.G., B.A., K.H.-X.), Service d'Hématologie (S. Choquet), Service de Neuro-Radiologie (N.M.-D.), Service d'Ophtalmologie (V.T.), Service de Médecine Nucléaire (A.K.), Service de Neuro-Pathologie (K.M.), Service d'Anatomie et Cytologies Pathologiques (F.C.), Service de Radiothérapie (L.F.), Service d'Hémato-Biologie (M.L.G.-T., M.C.), and Service de Neurochirurgie (B.M., M.P.), APHP, Groupe Hospitalier Pitié-Salpêtrière, Paris; Service d'Hématologie (C. Soussain), Institut Curie, Site Saint-Cloud; Service d'Hématologie (H.G.), CHU Lyon Sud; Service d'Hématologie (P.S., A.S.), Institut Bergonié, Bordeaux; Service de Neuro-Oncologie (O. Chinot), Aix-Marseille Université, CNRS, INP, AP-HM, CHU de la Timone, Marseille; Service de Neurologie (L.T., M.B.), CHU de Nancy; Service d'Hématologie (R.H.), Inserm U1236 Université de Rennes 1 (T.L.), CHU de Rennes; Service de Neurologie (G.A.), Hôpitaux Civils, Colmar; Service d'Hématologie (G.D.), CHU de Caen; Service d'Oncologie Médical (P.A.), Institut de Cancérologie de l'Ouest, Saint Herblain; Service d'Hématologie (C.M.-C.), CHU de Clermont-Ferrand; Service de Neurologie (A.A.), CHU de Toulouse; Service d'Oncologie Hématologique et de Thérapie Cellulaire (V.D.), CHU de Poitiers, INSERM, CIC 1402, Centre d'Investigation Clinique, Université de Poitiers; Service d'Oncologie Médicale (M.F.), Institut du Cancer de Montpellier Val d'Aurelle; Service d'Hématologie (F.J.), Centre Henri Becquerel, Rouen; Service d'Hématologie (A.C.), CHU de Besançon; Service d'Hématologie (M.P.M.-M.), CHU d'Angers; Service d'Hématologie (F.M., E.B.), CHRU de Lille; Service d'Hématologie (O. Casasnovas), CHU de Dijon; Service d'Onco-Hématologie (R.G.), CHU de Grenoble; Service d'Hématologie (L.M.F.), CHU de Strasbourg; Service d'Hématologie (J.A.), CHU de Limoges; Service d'Hématologie (J.-P.M.), CHU d'Amiens; Service d'Hématologie (A.T.), CHU de Brest; Service de Neurologie (C.C.) and Service d'Hématologie (A.W.), CHU de Nîmes; Clinique Courlancy (P.C.), Reims; Service d'Hématologie (J.T.), Hôpital Cochin, APHP, Paris; Service d'Hématologie Clinique (K.L.), Centre Hospitalier, Le Mans; Service d'Hématologie (C. Serrier), Centre Hospitalier de Perpignan; Service d'Hématologie (C. Haioun), Hôpital Henri Mondor, Créteil, APHP; Service d'Hématologie Clinique (S. Chebrek), Centre Hospitalier d'Avignon; Service d'Hématologie (J.O.B.), CHU de Clermont-Ferrand; Service d'Hématologie (L.O.), Institut Universitaire du Cancer de Toulouse; Service de Neuro-Oncologie (E.T.), Aix-Marseille Univ, CNRS, INP, AP-HM, CHU de la Timone; Service d'Ophtalmologie (N.C.), Institut Curie, Université Paris V Descartes et PSL (Paris Science et Lettre), Paris; and Service d'Hématologie et Thérapie Cellulaire (E.G.), Centre d'Investigations Cliniques INSERM U1517, Centre Hospitalier Universitaire, Université de Tours, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000008900DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238921PMC
March 2020

Successful Imatinib therapy as a bridge to transplant in an atypical myeloproliferative neoplasm.

Curr Res Transl Med 2019 11 30;67(4):149-151. Epub 2019 May 30.

Caen University Hospital, Hematology Institute, France; Caen Normandy University, School of Medicine, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.retram.2019.04.003DOI Listing
November 2019

[F]-Fludarabine for Hematological Malignancies.

Front Med (Lausanne) 2019 17;6:77. Epub 2019 Apr 17.

Department of Hematology, University Hospital Center of Caen, Caen, France.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fmed.2019.00077/
Publisher Site
http://dx.doi.org/10.3389/fmed.2019.00077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478790PMC
April 2019

Usefulness of Flow Cytometry for the Detection of Cutaneous Localization in Malignant Hematologic Disorders.

Cytometry B Clin Cytom 2019 07 3;96(4):283-293. Epub 2019 May 3.

Laboratoire d'hématologie, CHU de Caen, Calvados, 14033 Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21784DOI Listing
July 2019

Be ever cautious until the truth is proven.

Am J Hematol 2019 04 31;94(4):E106. Epub 2019 Jan 31.

Hematology Institute, University Hospital, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25410DOI Listing
April 2019

[Evaluation of management disparity in patients with chronic lymphocytic leukemia in France].

Bull Cancer 2018 Dec 2;105(12):1147-1156. Epub 2018 Nov 2.

CHU de Caen, laboratoire d'hématologie, avenue de la Côte-de-Nacre, 14000 Caen, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00074551183027
Publisher Site
http://dx.doi.org/10.1016/j.bulcan.2018.08.014DOI Listing
December 2018

Diffuse large B-cell lymphoma chemotherapy reveals a combined immunodeficiency syndrome in cartilage hair hypoplasia.

Swiss Med Wkly 2018 24;148:w14606. Epub 2018 Apr 24.

CHU de Caen, Department of Internal Medicine and Clinical Immunology, Caen, France.

View Article

Download full-text PDF

Source
https://doi.emh.ch/smw.2018.14606
Publisher Site
http://dx.doi.org/10.4414/smw.2018.14606DOI Listing
October 2018

Combining baseline TMTV and gene profiling for a better risk stratification in diffuse large B cell lymphoma.

Eur J Nucl Med Mol Imaging 2018 05 17;45(5):677-679. Epub 2018 Feb 17.

Normandie University, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-018-3966-7DOI Listing
May 2018

Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease.

Clin Gastroenterol Hepatol 2018 06 16;16(6):908-917.e2. Epub 2017 Dec 16.

University of Lille, Inserm, CHU Lille, U995 - LIRIC - Lille Inflammation Research International Center, Lille, France; University of Lille, CHU Lille, Department of Nutrition, Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2017.12.024DOI Listing
June 2018

Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?

J Nucl Med 2018 07 14;59(7):1049-1055. Epub 2017 Dec 14.

Nuclear Medicine Department, Caen University Hospital, Caen, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.117.202721DOI Listing
July 2018

[Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

Bull Cancer 2017 Dec 22;104(12S):S131-S135. Epub 2017 Nov 22.

Universitätsklinikum Aachen, Klinik für Onkologie, Hämatologie und Stammzelltransplantation, Aachen, Allemagne; Institut de cancérologie Lucien-Neuwirth, département d'hématologie clinique, Saint-Priest-en-Jarez, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.10.018DOI Listing
December 2017

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

N Engl J Med 2017 09;377(13):1250-1260

From Service d'Hématologie Clinique (S.L.G., T.G.), Service d'Anatomopathologie (A.M.), and Service d'Hématologie Biologique (M.C.B.), Hôtel-Dieu Centre Hospitalier Universitaire (CHU) de Nantes, and Centre de Recherche en Cancérologie et Immunologie (S.L.G., M.C.B.) and Faculté de Médecine (S.L.G.), Université de Nantes, Nantes, Hemato-Oncologie, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Université Diderot Sorbonne Paris-Cité (C.T.), Université Descartes (C.T.), Département d'Hématologie, Faculté de Médecine, Université Paris-Sud (V.R.), Département d'Anatomopathologie (D.C.) and Département d'Hématologie (O.H.), Necker Hospital, APHP, Sorbonne Paris-Cité, and INSERM Unité 1163 et Centre National de la Recherche Scientifique (CNRS) Équipe de Recherche Labellisée 8654, Imagine Institute (O.H.), Paris, Département d'Hématologie, Institut Universitaire du Cancer-Oncopole de Toulouse, Toulouse (L.O.), Service d'Hématologie Clinique et Thérapie Cellulaire, CHU de Bordeaux, Bordeaux (K.B.), Service d'Hématologie et Thérapie Cellulaire, CHU de Tours, Tours (C.D.), Service d'Hématologie, CHU d'Amiens, Amiens (G.D.), INSERM, Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif (V.R.), Département d'Hématologie, CHU de Nancy, Nancy (P.F.), INSERM Unité 954, Vandoeuvre (P.F.), Service d'Hématologie Clinique, CHU de Dijon, and INSERM Unité Mixte de Recherche 1231, Dijon (O.C.), Service d'Hématologie, Centre Hospitalier d'Avignon, Avignon (H.Z.), Lymphoid Malignancies Unit, Hôpital Henri Mondor, APHP, Créteil (C.H.), Service d'Hématologie du Centre Hospitalier de Vendée, La Roche-sur-Yon (H.M.), Service Hématologie Clinique (R.H.) and Département d'Hématologie (T.L.), CHU de Rennes, INSERM Unité 917 (R.H.), and INSERM Unité 1236 (T.L.), Rennes, Département d'Hematology, Centre Henri-Becquerel et Université de Normandie Unité 1245, Rouen (F.J., H.T.), Service d'Hématologie Clinique Adulte et de Thérapie Cellulaire, CHU de Clermont-Ferrand et Université Clermont Auvergne, Clermont-Ferrand (O.T.), Service d'Hématologie, Clinique Victor Hugo, Le Mans (K.L.D.), Department of Hematology, Université de Lille, Groupe de Recherche sur les Formes Injectables et les Technologies Associées, and CHU de Lille, Lille (F.M.), Département d'Hématologie Clinique, CHU de Montpellier, CNRS UMR 5235, Montpellier (G.C.), Service d'Oncologie et d'Hématologie, Hôpitaux Universitaires de Strasbourg, Strasbourg (L.-M.F.), INSERM 1209, CNRS UMR 5309, Faculté de Médecine, Université Grenoble Alpes (M.C., R.G.), Institute for Advanced Biosciences (M.C.), and Laboratoire de Génétique Onco-hématologie (M.C.) and Faculté de Médecine (R.G.), CHU de Grenoble Alpes, Grenoble, Service d'Hématologie, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite (G.S.), and Université Claude Bernard Lyon 1 and Cancer Research Center of Lyon, INSERM 1052 CNRS 5286 Lyon, Lyon (G.S.) - all in France; and Département d'Hématologie, Cliniques Universitaires Saint-Luc-Université Catholique de Louvain, Brussels (E.V.D.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1701769DOI Listing
September 2017

ZOHé: A Prospective Study of the Use of Biosimilar Filgrastim Zarzio in Clinical Practice in Patients Treated With Chemotherapy for Lymphoid Malignancies.

Clin Lymphoma Myeloma Leuk 2017 06 10;17(6):362-369.e2. Epub 2017 May 10.

Institut de Cancérologie de l'Ouest René Gauducheau, Saint Herblain, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.05.002DOI Listing
June 2017

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Lancet 2017 02 7;389(10069):612-620. Epub 2017 Jan 7.

Department of Hematology, Université Paris Descartes, Hôpital Necker Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France; Institut Imagine INSERM U1163 and CNRS ERL8654, Université Paris Descartes, Hôpital Necker Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France; AB Science, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://dx.doi.org/10.1016/S0140-6736(16)31403-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5985971PMC
February 2017

Influence of factor VIII level and its inhibitor titer on the therapeutic response to corticosteroids alone in the management of acquired hemophilia: A retrospective single-center study.

Medicine (Baltimore) 2016 Nov;95(48):e5232

aDepartment of Internal Medicine bDepartment of Biostatistics and Clinical Research cHaematology Laboratory and Haemophilia Reference Centre dDepartment of Clinical Haematology, Centre Hospitalier Universitaire de Caen, Caen, France.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00005792-201611290-0000
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000005232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134779PMC
November 2016

Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice.

Haematologica 2016 10;101(10):1133-1143

Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2016.146563DOI Listing
October 2016

T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.

Blood 2016 08 23;128(8):1081-92. Epub 2016 Jun 23.

Pôle Biologie and INSERM, Unité Mixte de Recherche U917, Equipe Labellisée Ligue Contre le Cancer, Rennes, France; Université Rennes 1, Unité Mixte de Recherche U917, Rennes, France; Etablissement Français du Sang Bretagne, Rennes, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-08-662783DOI Listing
August 2016

Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients.

Medicine (Baltimore) 2016 Jun;95(24):e3901

aService de médecine interne, Hôpital Tenon, Université Pierre et Marie Curie, Paris, France bService de Médecine Interne, CHU de Caen, Université Basse Normandie, Caen, France cInstitut d'Hématologie de Basse Normandie, Centre Hospitalier Universitaire, Université de Caen-Basse Normandie, Caen, France dFaculté de Médecine et AP-HP Necker-Enfants Malades, Centre de Référence des Mastocytoses, Paris Cedex 15, France eInserm, U1068, CRCM [Signaling, Hematopoiesis and Mechanism of Oncogenesis], Institut Paoli-Calmettes,Marseille, Aix-Marseille Univ, CNRS, UMR7258, Marseille, France fMastocytosis Competence Center of Midi-Pyrénées, Department of Dermatology, Toulouse University Hospital, Toulouse, France gService de Médecine Interne, Université Claude Bernard Lyon1, Groupe Hospitalier Lyon-Sud. Chemin du Grand Revoyet, Pierre Bénite, France hService de Dermatologie, Hôpital Tenon, Université Pierre et Marie Curie-Paris 6, Paris, France iService d'Hématologie Adultes, Université Paris Descartes, Paris Sorbonne Cité, Faculté de Médecine et AP-HP Necker-Enfants Malades, Institut Imagine, Université Paris Descartes, Paris Cedex 15, France jService de Médecine interne, Hôpital St Antoine, Université Pierre et Marie Curie-Paris 6, Paris, France kService de Médecine interne, Université de Rennes 1, Hôpital Sud CHU Rennes, Rennes, France lService de Médecine interne, Hôpital Pitié Salpêtrière, Université Pierre et Marie Curie-Paris 6, Paris, France mService de Médecine interne, CHU, Nantes, France nService de Médecine interne, Hôpital Européen Georges Pompidou, Université Paris 5, Paris, France oUniversité de Lille, UFR Médecine, Lille, France; CHRU Lille, Pôle Spécialités Médicales et Gérontologie, Département de Médecine Interne et Immunologie Clinique, Lille Cedex, France; Centre National de Référence Maladies Systémiques et Auto-immunes Rares (Sclérodermie Systémique), Lille Cedex, France; LIRIC UMR 995, EA2686, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000003901DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998476PMC
June 2016

A French National Survey on Clotting Disorders in Mastocytosis.

Medicine (Baltimore) 2015 Oct;94(40):e1414

From the French Reference Centre for Mastocytosis (CEREMAST), Necker Children's Hospital, Assistance Publique - Hôpitaux de Paris (APHP), France (ABC, GD, DC, CB, SB, LF, OL, OH, M-OC); Haemostasis and Thrombosis Unit, Haemophilia Clinic, Division of Haematology, St-Luc University Hospital, Brussels, Belgium (ABC, CH); Department of Internal Medicine, Caen University Hospital, France (AA); Department of Haematology, Caen University Hospital, France (GD); Department of Pathology, Necker Children's Hospital, APHP, France (DC); Department of Biological Haematology, Necker Children's Hospital, APHP, France (CB); Department of Haematology and Cell Therapy, Tours University Hospital, France (EG); Department of Internal and Vascular Medicine, Lyon Sud University Hospital, France (SD, ID); Department of Internal Medicine, Saint-Etienne University Hospital, France (PC); Department of Internal Medicine, Cochin Hospital, APHP, France (NC-C); Department of Internal Medicine, Lille University Hospital, France (DL); Infectious Diseases Department, Necker Children's Hospital, APHP, France (BP, OL); Department of Dermatology, Tenon University Hospital, APHP, France (SB); Department of Haematology, Necker Children's Hospital, APHP, France (LF, OH, M-OC); and Sorbonne Paris Cité, Paris Descartes University, Imagine Institute, Paris, France (LF, OL, OH, M-OC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000001414DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616764PMC
October 2015

New insights in the management of patients with hairy cell leukemia.

Curr Opin Oncol 2015 Sep;27(5):371-6

aLaboratoire Hématologie bService Hématologie Clinique, CHU Côte de Nacre, Caen, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000214DOI Listing
September 2015

Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.

Blood 2015 Aug 22;126(8):1009-16; quiz 1050. Epub 2015 May 22.

Centre de Référence des Mastocytoses, Hôpital Necker Enfants Malades, Paris V, IFR Necker, Paris, France; Service d'Hématologie, Faculté de Médecine Paris V, Université Sorbonne Paris-Cité et Assistance Publique-Hôpitaux de Paris, Hôpital Necker, Paris, France; Institut Imagine, Université Sorbonne Paris-Cité et Assistance Publique-Hôpitaux de Paris, Hôpital Necker, Paris, France; and Laboratoire "Cellular and Molecular Basis of Hematological Disorders and Therapeutic Implications," INSERM U1163, CNRS ERL 8254, Paris, France.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/early/2015/05/21/blood-2
Web Search
http://www.bloodjournal.org/content/bloodjournal/126/8/1009.
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-12-61
Publisher Site
http://dx.doi.org/10.1182/blood-2014-12-614743DOI Listing
August 2015

[The role of pre-transplant debulking treatment in patients undergoing allogeneic stem cell transplantation for high-risk myelodysplastic syndrome].

Bull Cancer 2015 Apr 19;102(4):340-8. Epub 2015 Mar 19.

CHRU de Lille, pôle spécialités médicales et gérontologie, service des maladies du sang, secteur allogreffe de cellules souches hématopoïétiques, 59037 Lille, France; Université de Lille, UFR médecine, 59000 Lille, France; Lyric U995, 59000 Lille, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.02.009DOI Listing
April 2015

Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy.

Transplantation 2015 Aug;99(8):1672-80

1 CHRU Lille, Pôle Spécialités Médicales et Gérontologie, Service des Maladies du Sang, Secteur Allogreffe de Cellules Souches Hématopoïétiques, F59037, Lille, France. 2 Université de Lille, UFR Médecine F59000, Lille, France. 3 Hematology Department, Caen University Hospital, Amiens, France. 4 Department of Biostatistics, Lille University Hospital, Lille, France. 5 Hematology Department and Hematopoietic Stem Cell Transplantation Unit, Saint-Louis Hospital, Paris, France. 6 Hematology Department, Lyon-Sud Hospital, Lyon, France. 7 Hematology Department, Nantes, France. 8 Hematology Department CH-Liège, Liège, Belgium. 9 Hematology Department, Pitié-Salpêtrière Hospital, Paris, France. 10 Hematology Department, Strasbourg University Hospital, Strasbourg, France. 11 Hematopoietic Stem Cell Transplantation Unit, Paoli Calmettes Institute, Marseille, France. 12 Hematology Department, Loire Oncology Institute (ICL), Saint Priest en Jarez, France. 13 Hematology Department, Nantes University Hospital, Nantes, France. 14 Hematology Department, Saint-Antoine Hospital, Paris, France. 15 Hematology Department, Toulouse University Hospital, Toulouse, France. 16 Hematology Department, Grenoble University Hospital, Grenoble, France. 17 Hematology Department, Bordeaux University Hospital, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/TP.0000000000000649DOI Listing
August 2015

Isolated flushes without permanent, fixed or other skin lesions in patients with systemic mastocytosis: a case series of 9 patients.

Eur J Dermatol 2015 Apr;25(2):182-4

Centre de Référence des Mastocytoses, AP-HP Necker-Enfants Malades, 156 Rue de Vaugirard, 75743 Paris, France, CNRS UMR 8147, Hôpital Necker-Enfants malades, Paris, France, Service de Médecine interne, Hôpital Tenon, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/ejd.2014.2484DOI Listing
April 2015

Bendamustine is effective in T-cell prolymphocytic leukaemia.

Br J Haematol 2015 Mar 15;168(6):916-9. Epub 2014 Oct 15.

Service des Maladies du Sang, Centre Hospitalier Régional et Universitaire de Lille, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13175DOI Listing
March 2015

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

J Clin Oncol 2014 Oct 25;32(29):3264-74. Epub 2014 Aug 25.

Celalettin Ustun, Ryan Shanley, Gregory Vercellotti, and Daniel Weisdorf, University of Minnesota, Minneapolis; William J. Hogan, Mayo Clinic, Rochester, MN; Andreas Reiter and Sebastian Kreil, Universitätsmedizin Mannheim, Mannheim; Herrad Baurmann, Stiftung Deutsche Klinik für Diagnostik, Wiesbaden; Bernd Gruhn, Jena University Hospital, Jena; Tanja Gromke, University of Essen, Essen; Eva Maria Wagner, Universitätsmedizin Mainz, Mainz; Martin Bornhäuser, Universitätsklinikum Dresden, Dresden; Christoph Schmid, Klinikum Augsburg, Ausburg, Germany; Bart L. Scott and H. Joachim Deeg, University of Washington, Seattle, WA; Ryotaro Nakamura, City of Hope National Medical Center, Duarte; Vinod Pullarkat, University of Southern California, Los Angeles, CA; Gandhi Damaj, Université de Caen, Faculté de Médecine, Caen; Faezeh Legrand, Nice University Hospital, Nice, and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC); Ibrahim Yakoub-agha, Centre Hospitalier Régionale Universitaire, Lille; Olivier Hermine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Université Paris 5 Faculté de Médecine et AP-HP Necker-Enfants Malades, and Centre de Référence des Mastocytoses, Paris, France; Miguel-Angel Perales and Esperanza B. Papadopoulos, Memorial Sloan-Kettering Cancer Center; Tsiporah Shore, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY; Robert Stuart, Medical University of South Carolina, Charleston, SC; Michael Doubek, Masaryk University, Brno, Czech Republic; Jack W. Hsu, University of Florida, Gainesville, FL; Eleni Tholouli, Manchester Royal Infirmary, Manchester, United Kingdom; Lucy A. Godley, University of Chicago, Chicago, IL; Livio Pagano, Università Cattolica del Sacro Cuore, Milan; Maria Teresa Van Lint, Istituto Di Ricovero e Cura a Carattere Scientifico San Martino-IST, Genova, Italy; Andrew Gilman, Levine Children's Hospital, Charlotte, NC; Tor Shwayder, Henry F

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876356PMC
October 2014

Molecular defects in mastocytosis: KIT and beyond KIT.

Immunol Allergy Clin North Am 2014 May;34(2):239-62

Molecular Oncology and Pharmacology, LBPA CNRS UMR8113, Ecole Normale Supérieure de Cachan, 61, Avenue du Président Wilson, Cachan 94235, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.iac.2014.01.009DOI Listing
May 2014

ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.

PLoS One 2014 21;9(1):e85362. Epub 2014 Jan 21.

Centre de Référence des Mastocytoses, Faculté de Médecine et AP-HP Necker-Enfants Malades, Paris, France ; CNRS UMR 8147 and Institut Imagine, AP-HP, Hôpital Necker-Enfants Malades, Paris, France ; Service d'Hématologie Adulte, Université Paris Descartes, Paris Sorbonne Cité, Faculté de Médecine et AP-HP Necker-Enfants Malades, Paris, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085362PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897447PMC
October 2014

Liquid chromatography-tandem mass spectrometry assay for therapeutic drug monitoring of the tyrosine kinase inhibitor, midostaurin, in plasma from patients with advanced systemic mastocytosis.

J Chromatogr B Analyt Technol Biomed Life Sci 2014 Jan 15;944:175-81. Epub 2013 Nov 15.

Hematology Department, Necker Hospital, 149 rue de Sèvres, Paris 75015, France; Centre de référence des mastocytoses (CEREMAST), Necker Hospital, 149 rue de Sèvres, Paris 75015, France; CNRS UMR 8147, University Paris V, 15 rue de l'école de médecine, Paris 75006, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2013.11.003DOI Listing
January 2014

L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm.

Br J Haematol 2013 Nov 12;163(4):543-5. Epub 2013 Aug 12.

Clinical Haematology Department, Amiens University Hospital, Amiens, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12523DOI Listing
November 2013

Leukocyte telomere length in mastocytosis: correlations with depression and perceived stress.

Brain Behav Immun 2014 Jan 1;35:51-7. Epub 2013 Aug 1.

Centre de référence des mastocytoses, Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker Enfants malades, Paris, France; Institut Imagine Université Paris Descartes, Sorbonne, Paris Cité, Hôpital Necker Enfants malades, Paris, France; CNRS UMR 8147, Hôpital Necker-Enfants malades, 149 rue des Sèvres, 75743 Paris Cedex 15, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbi.2013.07.009DOI Listing
January 2014

Gastrointestinal manifestations in mastocytosis: a study of 83 patients.

J Allergy Clin Immunol 2013 Oct 26;132(4):866-73.e1-3. Epub 2013 Jul 26.

Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine, AP-HP, Université Pierre et Marie Curie-Paris 6, Paris, France; Equipe AVENIR, Laboratoire INSERM U1057/UMR CNRS 7203, Université Pierre et Marie Curie 6, Paris, France; Equipe Interactions des bactéries commensales et probiotiques avec l'hôte, MICALIS, INRA, Jouy en Josas, France; Centre de Référence des Mastocytoses, Faculté de Médecine et AP-HP Necker-Enfants Malades, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2013.05.026DOI Listing
October 2013

[The "lymph node circuit", clinical nursing expertise].

Rev Infirm 2013 Feb(188):41-3

Service d'hématologie clinique et thérapie cellulaire, CHU d'Amiens, Amiens.

View Article

Download full-text PDF

Source
February 2013

Mast cell leukemia.

Blood 2013 Feb 14;121(8):1285-95. Epub 2012 Dec 14.

Centre de Référence des Mastocytoses, Faculté de Médecine et Assistance Publique-Hopitaux de Paris (AP-HP) Necker-Enfants Malades, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-07-442400DOI Listing
February 2013

Relocalization of KIT D816V to cell surface after dasatinib treatment: potential clinical implications.

Clin Lymphoma Myeloma Leuk 2013 Feb 3;13(1):62-9. Epub 2012 Nov 3.

CNRS UMR 8113, Laboratoire de Biologie et Pharmacologie Appliquée, École Normale Supérieure de Cachan, Cachan, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2012.08.004DOI Listing
February 2013

In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells.

Blood 2012 Dec 16;120(24):4846-9. Epub 2012 Oct 16.

Inserm U1068, Centre de Recherche en Cancérologie de Marseille, Centre de Référence des Mastocytoses, Institut Paoli-Calmettes, Université de la Méditerranée, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-12-397588DOI Listing
December 2012

Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive.

Case Rep Hematol 2012 10;2012:517546. Epub 2012 Sep 10.

Service d'Hématologie, Centre Hospitalier Universitaire, Avenue Laennec, 80054 Amiens, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/517546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444844PMC
September 2012

[Systemic mastocytosis. Osteoporotic fracture as a manifestation].

Rev Prat 2011 Oct;61(8):1047-50

Centre de référence des mastocytoses (CEREMAST), faculté Necker, 156, rue de Vaugirard, 75730 Paris Cedex 15.

View Article

Download full-text PDF

Source
October 2011

Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.

PLoS One 2011 21;6(10):e26375. Epub 2011 Oct 21.

Université Paris Descartes, Sorbonne, Paris Cité, Service d'hématologie, Centre de référence des mastocytoses, Hôpital Necker Enfants malades, Paris, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026375PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198767PMC
May 2012

Blood CD34-c-Kit+ cell rate correlates with aggressive forms of systemic mastocytosis and behaves like a mast cell precursor.

Blood 2011 Nov 30;118(19):5246-9. Epub 2011 Aug 30.

Service d'Hématologie Adultes et Centre de Référence sur les Mastocytoses, Hôpital Necker-Enfants Malades, Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-02-335950DOI Listing
November 2011

Thalidomide in advanced mastocytosis.

Br J Haematol 2008 Apr 26;141(2):249-53. Epub 2008 Feb 26.

Department of Haematology, Centre Hospitalier Universitaire, Amiens, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07038.xDOI Listing
April 2008